Skip to content

Dexpanthenol Attenuates Doxorubicin-Induced Cardiotoxicity by Modulating Oxidative Stress, Inflammation, and Apoptosis

Sep 2026 · Cardiovascular Toxicology · Vol 26 · 0 citations · 55 references
Medicine

TL;DR

DEX exerts a partial but mechanistically coherent cardioprotective effect against DOX-induced cardiotoxicity, chiefly through attenuation of TLR4/NF-κB–driven inflammation and caspase-3 signaling, and this findings support its evaluation as a multi-target adjunct in cardio-oncology.

View source

Similar papers

Oct 2026

Morin mitigates doxorubicin-induced cardiotoxicity via suppression of oxidative stress, inflammation, and structural remodeling.

The clinical use of the anticancer drug doxorubicin is restricted by its ability to cause cardiotoxicity, often progressing to heart failure. Current cardiovascular treatments fail to restore cardiac function or improve long-term survival rates, demanding alternative therapeutic approaches to minimize the cardiotoxicit...

S. Elsayed, N. Fares, S. Elsharkawy et al. · 0 citations
Oct 2026

Hesperidin attenuates methotrexate-induced cardiotoxicity: Modulation of Nrf2 antioxidant defense and NF-κB/iNOS proinflammatory signaling.

Results indicate that hesperidin effectively attenuates MTX-induced cardiotoxicity and that HES may hold potential as a supplementary agent to minimize the cardiotoxic complications associated with MTX regimens, warranting further investigation.

M. Eldesoqui, E. Albadawi, O. Erfan et al. · 0 citations
Sep 2026

Cardioprotective role of vincamine in cyclophosphamide-induced cardiotoxicity through modulation of AMPK/SIRT1, PI3K/Akt, and MAPK pathways.

VIN attenuated changes in the AMPK/SIRT1 and PI3K/Akt axes, MAPK, TLR4/NF-κB p65 signaling, as well as NLRP3-related signaling in a dose-responsive manner, and its cardioprotective effects were accompanied by improved redox balance, increased AMPK/SIRT1 and PI3K/Akt expression, reduced phosphorylated MAPK abundance, an...

Mohammed Tarek Seddek, A. Awad, Marwa E. Elsherbiny et al. · 0 citations
Open access Nov 2026

Nanocurcumin Attenuates Doxorubicin‐Induced Cardiotoxicity by Activating the Wnt/β‐Catenin/GSK‐3β Signaling Axis in Wistar Rats

ABSTRACT Doxorubicin (DOX)–induced cardiotoxicity remains a major therapeutic limitation, emerging at the intersection of oxidative stress, mitochondrial impairment, and disruption of survival signaling pathways. The Wnt/β‑catenin–GSK‑3β pathway is an essential regulator of cardiomyocyte survival. To assess the cardiop...

Noha A. Alshuwayer, Q. Alqahtani, Marwa H. Hussein et al. · 0 citations
Open access Oct 2026

Exogenous ketosis fails to mitigate cardiac dysfunction, mitochondrial and inflammatory dysregulation in acute doxorubicin-induced cardiotoxicity

Doxorubicin (DOX)-induced cardiotoxicity is driven by mitochondrial dysfunction, oxidative stress and inflammatory activation. In pathological conditions, the heart undergoes metabolic remodelling, increasing its reliance on ketone bodies (KB) as an auxiliary energy substrate. Although exogenous KB have demonstra...

N. F. Ferreira, P. Ballin, R. P. Cabral-Filho et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.